Switzerland· 60080001
MDT-Combi MB Erwachsene und Jugendliche, Kapseln und Tabletten
A drugs for treatment of lepra product, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category A.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Manufacturer
- Novartis Pharma Schweiz AG
- Country
- Switzerland (CH)
- ATC code
- J04BA
- ATC class
- Drugs for treatment of lepra
- Swissmedic category
- A
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J04BA
Drugs for treatment of lepra, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/97701ad5-ba6b-4cd5-ade8-68a32e0980a6 GET /v1/drugs/97701ad5-ba6b-4cd5-ade8-68a32e0980a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about MDT-Combi.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.